Advertisement
Case report| Volume 20, ISSUE 2, P179-181, February 1985

Download started.

Ok

High-dose bromocriptine in a case of tardive dystonia

  • Daniel J. Luchins
    Correspondence
    Address reprint requests to: Daniel J. Luchins. Department of Psychiatry. Pritzker School of Medicine, University of Chicago, 5841 South Maryland Avenue. Chicago. lllinois 60637 USA
    Footnotes
    Affiliations
    From the Department of Psychiatry, Pritzker School of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Search for articles by this author
  • Morris Goldman
    Footnotes
    Affiliations
    From the Department of Psychiatry, Pritzker School of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Search for articles by this author
  • Author Footnotes
    1 We would like to thank Dr. Stephen M. Stahl for the suggestion that high-dose bromocriptine be tried in this patient.
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Burke R.E.
        • Fahn S.
        • Jankovics J.
        • et al.
        Tardive dystonia: Late onset and persistent dystonia caused by antipsychotic drugs.
        Neurology (NY). 1982; 32: 335-346
        • Friedhoff A.J.
        • Alpert M.
        Receptor sensitivity modification as a potential treatment.
        in: Lipton M.A. DiMascio A. Killam K.F. Psychopharmacology—A Generation of Progress. Raven Press, New York1978: 797-802
        • Garg B.P.
        Dystonia musculorum deformans: Implications of therapeutic response to levodopa and carbamazepine.
        Arch Neurol. 1982; 39: 376-377
        • Geller M.
        • Kaplan B.
        • Christoff N.
        Treatment of dystonic symptoms with carbamazepine.
        Advan Neurol. 1976; 14: 403-410
        • Girotti F.
        • Seigliano G.
        • Nardocci N.
        • et al.
        Idiopathic dystonia: Neuropharmacological study.
        J Neurol. 1982; 227: 239-247
        • Harenko A.
        Retrocollis as an irreversible late complication of neuroleptic medication.
        Acta Neurol Scand (Suppl). 1967; 43: 145-146
        • Keegan D.L.
        • Rajput A.H.
        Drug induced dystonia tardia: Treatment with l-dopa.
        Dis Nerv Syst. 1973; 38: 167-169
        • Lang A.E.
        • Sheehy M.P.
        • Marsden C.D.
        Acute anticholinergic action in focal dystonia.
        Advan Neurol. 1983; 17: 193-200
        • Stahl S.M.
        • Berger P.A.
        Bromocriptine, physostigmine, and neurotransmitter mechanisms in dystonias.
        Neurology (NY). 1982; 32: 889-892
        • Ziegler D.K.
        Prolonged relief of dystonic movements with diazepam.
        Neurology (NY). 1981; 31: 1457-1458